Anbio Biotechnology (NNNN) Payables (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Anbio Biotechnology has reported Payables over the past 2 years, most recently at $1.6 million for Q4 2024.

• Quarterly results put Payables at $1.6 million for Q4 2024, up 4551.29% from a year ago — trailing twelve months through Dec 2024 was $1.6 million (up 4551.29% YoY), and the annual figure for FY2024 was $1.6 million, up 4551.29%.
• Payables for Q4 2024 was $1.6 million at Anbio Biotechnology, up from $34942.0 in the prior quarter.
• Over the last five years, Payables for NNNN hit a ceiling of $1.6 million in Q4 2024 and a floor of $34942.0 in Q4 2023.

Peer Comparison